DiaMedica Therapeutics Ownership | Who Owns DiaMedica Therapeutics?


OverviewForecastRevenueFinancialsChartTranscripts

DiaMedica Therapeutics Ownership Summary


DiaMedica Therapeutics is owned by 2.48% institutional investors, 26.28% insiders, and 71.24% retail investors. Cooperman leon g is the largest institutional shareholder, holding 7.61% of DMAC shares. Vanguard US Total Market Shares ETF is the top mutual fund, with 1.74% of its assets in DiaMedica Therapeutics shares.

DMAC Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockDiaMedica Therapeutics2.48%26.28%71.24%
SectorHealthcare Stocks 42.54%10.83%46.63%
IndustryBiotech Stocks 45.22%10.75%44.04%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Cooperman leon g3.27M7.61%$17.64M
Blackrock funding, inc. /de1.68M3.91%$11.53M
Paragon associates & paragon associates ii joint venture875.00K2.04%$6.01M
Geode capital management711.82K1.66%$4.89M
Vanguard group664.58K1.55%$4.57M
Morgan stanley579.59K1.35%$3.98M
First manhattan co. llc.505.00K1.18%$3.47M
State street476.58K1.11%$3.27M
Bleichroeder lp382.32K0.89%$2.63M
Susquehanna group, llp374.85K0.88%$2.04M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Paragon associates & paragon associates ii joint venture875.00K10.72%$6.01M
Corient ia132.50K0.68%$910.27K
Cooperman leon g3.27M0.55%$17.64M
Bleichroeder lp382.32K0.51%$2.63M
Catalyst financial partners38.46K0.03%$264.20K
Private capital management50.00K0.03%$343.50K
Magnolia capital advisors10.00K0.02%$68.70K
Meridian wealth management51.67K0.01%$354.94K
First manhattan co. llc.505.00K0.01%$3.47M
Stonebridge capital advisors17.50K0.01%$120.22K

Top Buyers

HolderShares% AssetsChange
Cooperman leon g3.27M0.55%1.62M
Blackrock funding, inc. /de1.68M0.00%486.33K
Morgan stanley579.59K0.00%339.11K
Susquehanna group, llp374.85K0.00%273.39K
Paragon associates & paragon associates ii joint venture875.00K10.72%225.00K

Top Sellers

HolderShares% AssetsChange
Vanguard group664.58K0.00%-870.48K
Aristides capital---106.33K
First manhattan co. llc.505.00K0.01%-101.44K
683 capital management---76.12K
Hrt financial lp---56.70K

New Positions

HolderShares% AssetsChangeValue
Ci private wealth140.00K0.00%140.00K$961.80K
Corient ia132.50K0.68%132.50K$910.27K
Cantor fitzgerald, l. p.100.00K0.01%100.00K$687.00K
Private capital management50.00K0.03%50.00K$343.50K
Creative planning38.79K0.00%38.79K$266.49K

Sold Out

HolderChange
Federation des caisses desjardins du quebec-230.00
Point72 (difc)-642.00
Legend financial advisors-1.00K
Cubist systematic strategies-3.21K
Sg americas securities-10.88K

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Sep 30, 202519-65.45%1,067,231-87.45%20.63%10-73.68%4-
Jun 30, 202557-5.00%8,620,53214.72%206.52%3911.43%5-50.00%
Mar 31, 20256027.66%7,514,09211.67%177.08%3525.00%10100.00%
Dec 31, 20244711.90%6,729,01220.58%159.24%2827.27%5-16.67%
Sep 30, 20244223.53%5,580,41110.22%137.34%2283.33%6-33.33%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard US Total Market Shares ETF747.20K1.74%-
Vanguard Total Stock Mkt Idx Inv839.16K1.63%-18.51K
iShares Russell 2000 ETF452.87K0.88%-
Vanguard Institutional Extnd Mkt Idx Tr306.18K0.59%-139.52K
Fidelity Small Cap Index263.29K0.51%263.29K
iShares Russell 2000 Growth ETF243.51K0.47%-
Fidelity Extended Market Index140.79K0.27%-1.16K
Vanguard Russell 2000 ETF126.89K0.25%-7.49K
Jacob Discovery Fd Instl85.73K0.20%-4.00K
State St Russell Sm Cap® Indx SL Cl I92.50K0.18%-

Recent Insider Transactions


DateNameRoleActivityValue
Nov 21, 2025STAHLBERG JAN-Buy$1.55M
Nov 20, 2025STAHLBERG JAN-Buy$951.21K
Nov 25, 2025STAHLBERG JAN-Buy$626.82K
Nov 24, 2025STAHLBERG JAN-Buy$317.72K
Nov 19, 2025STAHLBERG JAN-Buy$1.73M

Insider Transactions Trends


DateBuySell
2025 Q33-
2025 Q2--
2025 Q1--
2024 Q22-
2024 Q1--

DMAC Ownership FAQ


Who Owns DiaMedica Therapeutics?

DiaMedica Therapeutics shareholders are primarily institutional investors at 2.48%, followed by 26.28% insiders and 71.24% retail investors. The average institutional ownership in DiaMedica Therapeutics's industry, Biotech Stocks , is 45.22%, which DiaMedica Therapeutics falls below.

Who owns the most shares of DiaMedica Therapeutics?

DiaMedica Therapeutics’s largest shareholders are Cooperman leon g (3.27M shares, 7.61%), Blackrock funding, inc. /de (1.68M shares, 3.91%), and Paragon associates & paragon associates ii joint venture (875K shares, 2.04%). Together, they hold 13.55% of DiaMedica Therapeutics’s total shares outstanding.

Does Blackrock own DiaMedica Therapeutics?

BlackRock is not among the top 10 institutional shareholders of DiaMedica Therapeutics.

Who is DiaMedica Therapeutics’s biggest shareholder by percentage of total assets invested?

Paragon associates & paragon associates ii joint venture is DiaMedica Therapeutics’s biggest shareholder by percentage of total assets invested, with 10.72% of its assets in 875K DiaMedica Therapeutics shares, valued at 6.01M$.

Who is the top mutual fund holder of DiaMedica Therapeutics shares?

Vanguard US Total Market Shares ETF is the top mutual fund holder of DiaMedica Therapeutics shares, with 1.74% of its total shares outstanding invested in 747.2K DiaMedica Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools